NCT00475176View on ClinicalTrials.gov

S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Chronic Hepatitis C
Interventions
DRUG

Peginterferon alfa-2a

DRUG

Ribavirin

DRUG

S-adenosyl methionine for Chronic Liver Disease

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00475176 - S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter